The loss of Wnt/β-catenin activity seen in the existing RNF43/EP300-mutant cancer cell lines (Figure 1H and Figure 4G) is likely due to the loss of any selective pressure to maintain Wnt signaling in these cells once p300 is mutated. The gene discussed is RNF43; the disease is cancer.